Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07198009 · ClinicalTrials.gov registry record · NA
2-HOBA Supplementation in People With Elevated Lipoprotein(a)
A NA study, sponsored by The Miriam Hospital.
- Not yet
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT07198009 is a NA study that has not yet begun recruiting, run by The Miriam Hospital. The registered enrollment target is 10 participants.
The verdict
NCT07198009, a NA study, has not yet begun recruiting, sponsored by The Miriam Hospital.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn if a natural supplement called 2-hydroxybenzylamine (2-HOBA) can reduce harmful oxidized lipids and improve the function of lipoprotein(a) in adults with high lipoprotein(a) levels. The main questions it aims to answer are: Does 2-HOBA lower oxidized phospholipids on lipoprotein(a)? Does 2-HOBA reduce markers of inflammation and blood clotting in the blood? Participants will: Take 2-HOBA capsules (400 mg, three times daily with meals) for 6 weeks Provide blood and urine samples at the beginning, middle, and end of the study Have lab tests to measure changes in lipids, inflammation, and clotting markers
Interventions
- DIETARY_SUPPLEMENT 2-HOBA (Hobamine)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2025-11-01 |
| Est. Completion | 2026-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07198009
The ClinicalTrials.gov registry entry for NCT07198009 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Miriam Hospital, which has 136 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 2-HOBA (Hobamine) is the first listed.
NCT07198009 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07198009 about?
NCT07198009 is a clinical study titled "2-HOBA Supplementation in People With Elevated Lipoprotein(a)". The goal of this clinical trial is to learn if a natural supplement called 2-hydroxybenzylamine (2-HOBA) can reduce harmful oxidized lipids and improve the function of lipoprotein(a) in adults with high lipoprotein(a) levels. The main questions it aims to answer are: Does 2-HOBA lower oxidized pho...
What is the current status of trial NCT07198009?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2025-11-01. Estimated completion is 2026-11.
What interventions are being tested in trial NCT07198009?
The interventions under investigation include: 2-HOBA (Hobamine) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07198009?
This trial is sponsored by The Miriam Hospital, which has 136 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.